Work

Ketamine for Depression: Where Do We Go from Here?

Year: 2012

Type: review

Study design: Systematic Review

Source: Biological Psychiatry

DOI: 10.1016/j.biopsych.2012.05.003

Authors: Marije aan het Rot, Carlos A. Zarate, Dennis S. Charney, Sanjay J. Mathew

Institutions: University of Groningen, National Institute of Mental Health, Icahn School of Medicine at Mount Sinai, Michael E. DeBakey VA Medical Center, Baylor College of Medicine

Language: English

Topic: Treatment of Major Depression

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Veterans Affairs, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, National Institutes of Health, National Institute of Mental Health

Awards: Optimization of IV Ketamine for Treatment Resistant Major Depression, G6508566194, Glutamatergic Modulators for Rapid and Sustained Antidepressant Effect

OpenAlex ID: W2044325416

FWCI: 6.365

Cites: 64

Cited by: 418

Related to: 10